Bio Green Med Solution, Inc. (BGMS) vs Imunon, Inc. (IMNN)

Bio Green Med Solution, Inc. and Imunon, Inc. are both Biotechnology companies. Bio Green Med Solution, Inc. and Imunon, Inc. are of similar size ($6.0M and $5.5M). Bio Green Med Solution, Inc. grew revenue faster over the last twelve months: 2,414.9% against 0.00%. Imunon, Inc. has the higher net margin (0.00% vs −715.5%) and the lower return on invested capital (−324.4% vs −67.3%). Across the 18 metrics below, Bio Green Med Solution, Inc. leads on 12 and Imunon, Inc. on 6.

Valuation

Metric BGMS IMNN Biotechnology median
P/E n/m n/m 8.50
P/S 2.74 10.67 9.71
P/B 0.71 2.76 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 0.70 8.01 9.21
Earnings yield (400.00%) (375.49%) (33.15%)
Free cash flow yield (19.67%) (284.77%) (25.50%)

Profitability

Metric BGMS IMNN Biotechnology median
Gross margin 19.34% 0.00% 65.16%
Operating margin (194.95%) 0.00% 0.00%
Net margin (715.48%) 0.00% 0.00%
Free cash flow margin (59.00%) 0.00% 0.00%
Return on equity (246.85%) (641.02%) (56.36%)
Return on assets (217.30%) (123.93%) (48.04%)
Return on invested capital (67.28%) (324.37%) 0.00%

Growth

Metric BGMS IMNN Biotechnology median
Revenue growth (TTM) 2,414.86% 0.00% 6.02%
EPS growth (last fiscal year) 98.71% 67.66% 30.26%
Revenue growth, 5-year CAGR (17.41%) 0.00% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGMS IMNN Biotechnology median
Debt to equity 0.00 1.32 0.00
Current ratio 8.63 1.82 4.72
Net debt to EBITDA 0.42 0.63 0.96

Dividend

Metric BGMS IMNN Biotechnology median
Dividend yield 0.00% — 0.09%
Payout ratio — — —

Size

Metric BGMS IMNN Biotechnology median
Market cap 5.51m 5.95m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack